ANTIDEPRESSIVI TRICICLICI PER IL COLON IRRITABILE: IL COMMENTO DI PHILIP SCHOENFELD SUL TRIAL “ATLANTIS” (Lancet 2023; 402: 1773-85.)-DA “EVIDENCE-BASED GI, AN ACG PUBLICATION” (FREE) (COPIONI!)
Low-dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS study Philip Schoenfeld This summary reviews Ford AC, Wright-Hughes A, Alderson S, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet 2023; 402: 1773-85. Correspondence…

